Chronic Sinusitis
2
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Monoclonal Antibody
1100%
+ 3 programs with unclassified modality
Competitive Landscape
4 companies ranked by most advanced pipeline stage
CT
Chia Tai TianQing Pharmaceutical GroupChina - Lianyungang
1 program1
TQC2731 injectionPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Chia Tai TianQing Pharmaceutical GroupTQC2731 injection
Regenerondupilumab
Ondine BiomedicalPhotodisinfection
SanofiSeprapack Sinus Dressing
Clinical Trials (4)
Total enrollment: 33 patients across 4 trials
A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps
Start: Dec 2023Est. completion: Mar 2025
Phase 2Completed
Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Start: Oct 2020Est. completion: Sep 202533 patients
Phase 2Completed
Photodynamic Therapy for the Treatment of Chronic Rhinosinusitis
Start: May 2013Est. completion: Mar 2014
N/AUnknown
Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery
Start: Jun 2003Est. completion: May 2005
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space